HSA
INBX icon

Hussman Strategic Advisors’s Inhibrx INBX Stock Holding History

Hussman Strategic Advisors’s Portfolio INBX Stock Details INBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.98M Buy
+31,500
New +$3.16M 0.69% 42

Other funds holding INBX

S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $51.6B AUM 27.34% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Hussman Strategic Advisors's INBX Position: Q2 2026 in Review

Hussman Strategic Advisors opened a new position in Inhibrx (INBX) in Q2 2026: 31,500 shares worth $2.98M. The stake represents 0.69% of the portfolio and ranks #42 among its holdings.

34 funds tracked by Wall St. Rank hold INBX as of Q2 2026.

  • Hussman Strategic Advisors held 31,500 shares of Inhibrx worth $2.98M as of Q2 2026.
  • Inhibrx was a new Hussman Strategic Advisors position in Q2 2026.
  • Inhibrx made up 0.69% of Hussman Strategic Advisors's portfolio in Q2 2026, its #42 holding.
  • 34 funds tracked by Wall St. Rank held Inhibrx as of Q2 2026.

Based on Hussman Strategic Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.